Brief: Entera Bio reports Q2 results
11/08/2022 11:42
Aug 11 (Reuters) - Entera Bio Ltd 5DT.F :
* ENTERA BIO LTD - AS OF JUNE 30, 2022, ENTERA HAD CASH AND
CASH
EQUIVALENTS OF $17.3 MILLION
* ENTERA BIO LTD - EXPECTS THAT CURRENT CASH IS SUFFICIENT
TO FUND
OPERATIONS THROUGH Q2 OF 2023
Source text for Eikon: ID:nGNXwHYMT
Further company coverage: 5DT.F
Recent news on Entera Bio
See all newsBrief: Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., As Chief Medical Officer Ahead Of Planned Eb613 Phase 3 Initiation
Corrected: Israel's Entera Bio Q2 net loss widens
NASDAQ RESUMED AT 10:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
Brief: Entera Bio Announces Pricing Of Oversubscribed $275 Million Private Placement